OPi Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
5
OPi General Information
Description
Operator of a bio-pharmaceutical company in France. The company engages in developing and marketing therapeutic agents and monoclonal antibodies for treating rare and severe diseases.
Contact Information
Corporate Office
- Les Jardins d'Eole
- 3 allée des Séquoias
- 69760 Limonest
- France
Corporate Office
- Les Jardins d'Eole
- 3 allée des Séquoias
- 69760 Limonest
- France
OPi Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
OPi Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
OPi Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Snc Picot Angers | Paris, France | 1987 |
OPi FAQs
-
When was OPi founded?
OPi was founded in 1999.
-
Where is OPi headquartered?
OPi is headquartered in Limonest, France.
-
What industry is OPi in?
OPi’s primary industry is Biotechnology.
-
Is OPi a private or public company?
OPi is a Private company.
-
What is OPi’s current revenue?
The current revenue for OPi is .
-
How much funding has OPi raised over time?
OPi has raised $13.4M.
-
Who are OPi’s investors?
BioMérieux, Caisse des Depots Group, Innoveris, Rhône-Alpes Création, and Seventure are 5 of 7 investors who have invested in OPi.
-
When was OPi acquired?
OPi was acquired on 22-Mar-2007.
-
Who acquired OPi?
OPi was acquired by EUSA Pharma (UK).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process